Insider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Sells 5,000 Shares of Stock
MarketBeat
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) CEO Robert I. Blum sold 5,000 shares of the company's stock in a transaction on Monday, July 14th. The stock was sold at an average price of $38.15, for a total transaction of $190,750.00. Following the sale, the chief executive officer directly owned 393,108 shares in the company, valued at $14,997,070.20. This trade represents a 1.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.
NASDAQ:CYTK